Jennison Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117M | Sell |
238,402
-38,709
| -14% | -$21M | 0.08% | 115 |
|
|
2025
Q4 | $161M | Buy |
277,111
+25,644
| +10% | +$14.5M | 0.1% | 91 |
|
|
2025
Q3 | $122M | Buy |
251,467
+85,475
| +51% | +$39.8M | 0.07% | 113 |
|
|
2025
Q2 | $67.3M | Buy |
+165,992
| New | +$69.4M | 0.04% | 177 |
|
|
2024
Q3 | – | Sell |
-84,071
| Closed | -$46.5M | – | 643 |
|
|
2024
Q2 | $46.5M | Buy |
84,071
+535
| +0.6% | +$306K | 0.03% | 221 |
|
|
2024
Q1 | $48.6M | Buy |
83,536
+51
| +0.1% | +$28.6K | 0.03% | 219 |
|
|
2023
Q4 | $44.3M | Buy |
83,485
+564
| +0.7% | +$273K | 0.03% | 220 |
|
|
2023
Q3 | $42M | Sell |
82,921
-33,393
| -29% | -$17.8M | 0.04% | 197 |
|
|
2023
Q2 | $60.7M | Sell |
116,314
-1,589,185
| -93% | -$858M | 0.05% | 165 |
|
|
2023
Q1 | $983M | Buy |
1,705,499
+516,520
| +43% | +$291M | 0.9% | 34 |
|
|
2022
Q4 | $655M | Buy |
1,188,979
+400,867
| +51% | +$212M | 0.66% | 40 |
|
|
2022
Q3 | $400M | Buy |
788,112
+136,885
| +21% | +$76.6M | 0.4% | 49 |
|
|
2022
Q2 | $354M | Buy |
651,227
+525,014
| +416% | +$289M | 0.35% | 48 |
|
|
2022
Q1 | $74.5M | Sell |
126,213
-20,808
| -14% | -$12M | 0.05% | 152 |
|
|
2021
Q4 | $98.1M | Sell |
147,021
-110,033
| -43% | -$68.7M | 0.06% | 126 |
|
|
2021
Q3 | $147M | Buy |
257,054
+112,157
| +77% | +$61.6M | 0.1% | 93 |
|
|
2021
Q2 | $73.1M | Buy |
144,897
+127,702
| +743% | +$60.3M | 0.05% | 163 |
|
|
2021
Q1 | $7.85M | Sell |
17,195
-87,514
| -84% | -$41.8M | 0.01% | 444 |
|
|
2020
Q4 | $48.8M | Buy |
104,709
+36,937
| +55% | +$17.3M | 0.03% | 209 |
|
|
2020
Q3 | $29.9M | Buy |
67,772
+66,551
| +5,451% | +$27.5M | 0.02% | 259 |
|
|
2020
Q2 | $442K | Sell |
1,221
-59
| -5% | -$19.8K | ﹤0.01% | 604 |
|
|
2020
Q1 | $363K | Sell |
1,280
-693,276
| -100% | -$219M | ﹤0.01% | 602 |
|
|
2019
Q4 | $226M | Sell |
694,556
-158,084
| -19% | -$47.9M | 0.23% | 59 |
|
|
2019
Q3 | $248M | Buy |
852,640
+33,502
| +4% | +$9.59M | 0.26% | 56 |
|
|
2019
Q2 | $241M | Buy |
819,138
+788,686
| +2,590% | +$217M | 0.24% | 57 |
|
|
2019
Q1 | $8.34M | Sell |
30,452
-84,728
| -74% | -$21.1M | 0.01% | 443 |
|
|
2018
Q4 | $25.8M | Sell |
115,180
-43,544
| -27% | -$10.2M | 0.03% | 316 |
|
|
2018
Q3 | $38.7M | Sell |
158,724
-3,964
| -2% | -$912K | 0.04% | 294 |
|
|
2018
Q2 | $33.7M | Buy |
162,688
+17,497
| +12% | +$3.71M | 0.03% | 326 |
|
|
2018
Q1 | $30M | Sell |
145,191
-27,021
| -16% | -$5.67M | 0.03% | 339 |
|
|
2017
Q4 | $32.7M | Sell |
172,212
-1,498
| -0.9% | -$287K | 0.03% | 321 |
|
|
2017
Q3 | $32.9M | Sell |
173,710
-59,008
| -25% | -$10.7M | 0.03% | 331 |
|
|
2017
Q2 | $40.6M | Buy |
232,718
+476
| +0.2% | +$80K | 0.04% | 297 |
|
|
2017
Q1 | $35.7M | Sell |
232,242
-51,072
| -18% | -$7.81M | 0.04% | 330 |
|
|
2016
Q4 | $40M | Sell |
283,314
-6,388
| -2% | -$942K | 0.04% | 302 |
|
|
2016
Q3 | $46.1M | Sell |
289,702
-969
| -0.3% | -$149K | 0.05% | 290 |
|
|
2016
Q2 | $43M | Sell |
290,671
-8,148
| -3% | -$1.2M | 0.05% | 309 |
|
|
2016
Q1 | $42.3M | Buy |
298,819
+12,154
| +4% | +$1.63M | 0.04% | 311 |
|
|
2015
Q4 | $40.7M | Sell |
286,665
-176,140
| -38% | -$23.5M | 0.04% | 320 |
|
|
2015
Q3 | $56.6M | Sell |
462,805
-151,357
| -25% | -$19.7M | 0.06% | 276 |
|
|
2015
Q2 | $79.7M | Buy |
614,162
+55,528
| +10% | +$7.24M | 0.07% | 244 |
|
|
2015
Q1 | $75M | Buy |
558,634
+1,974
| +0.4% | +$254K | 0.07% | 261 |
|
|
2014
Q4 | $69.7M | Sell |
556,660
-163,496
| -23% | -$19.9M | 0.07% | 267 |
|
|
2014
Q3 | $87.6M | Buy |
720,156
+2,801
| +0.4% | +$341K | 0.08% | 221 |
|
|
2014
Q2 | $84.6M | Buy |
717,355
+26,150
| +4% | +$3.08M | 0.08% | 236 |
|
|
2014
Q1 | $83.1M | Buy |
691,205
+686
| +0.1% | +$81.6K | 0.08% | 228 |
|
|
2013
Q4 | $76.9M | Hold |
690,519
| – | – | 0.08% | 235 |
|
|
2013
Q3 | $63.6M | Buy |
690,519
+49,638
| +8% | +$4.49M | 0.07% | 256 |
|
|
2013
Q2 | $54.2M | Buy |
+640,881
| New | +$53.3M | 0.06% | 275 |
|
Other funds holding TMO
VCM
Jennison Associates's TMO Position: Q1 2026 in Review
Jennison Associates reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, selling an estimated $21M and leaving 238,402 shares worth $117M. The position accounts for 0.08% of the portfolio, ranked #115.
Jennison Associates first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $983M in Q1 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Jennison Associates held 238,402 shares of Thermo Fisher Scientific worth $117M as of Q1 2026.
- Jennison Associates sold 38,709 Thermo Fisher Scientific shares in Q1 2026, an estimated $21M.
- Thermo Fisher Scientific made up 0.08% of Jennison Associates's portfolio in Q1 2026, its #115 holding.
- Jennison Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
- Jennison Associates's Thermo Fisher Scientific position peaked at $983M in Q1 2023.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.